Skip to content

Effects of Oxycodone versus Sufentanil on Postoperative Analgesia and Sleep Quality: A Randomized, Double-blind, Controlled Trial Using Wearable Sleep Monitoring

Effects of Oxycodone versus Sufentanil on Postoperative Analgesia and Sleep Quality: A Randomized,Parallel-group, Controlled Trial Using Wearable Sleep Monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118982
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sleep disorder

Interventions

Oxycodone group:Oxycodone standard concentration configuration was used for postoperative analgesia pump
Sufentanil group:The standard concentration configuration of sufentanil was used for postoperative analgesia pump

Sponsors

The second people's hospital of neijiang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Adults aged 18–65 years; 2.ASA physical status I–III; 3.Scheduled for elective surgery under general anesthesia requiring postoperative PCIA; 4.Ability to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Pre-existing sleep disorders (PSQI > 7); 2.Chronic opioid use or opioid dependence; 3.Severe cardiopulmonary disease or diagnosed obstructive sleep apnea; 4.Significant hepatic or renal dysfunction; 5.Postoperative ICU admission or mechanical ventilation.

Design outcomes

Primary

MeasureTime frame
Mean sleep efficiency across postoperative nights 1–3;

Secondary

MeasureTime frame
Postoperative pain scores at 6, 12, 24, and 48 hours;Total opioid consumption within 48 hours;Incidence of adverse events (respiratory depression, nausea/vomiting, excessive sedation, delirium);

Countries

China

Contacts

Public ContactDeng Qianyao

The second people's hospital of neijiang

qianyaodeng@foxmail.com+86 183 8236 2546

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026